Engineering small‐molecule analogues of altiratinib via CREB‐regulated transcription co‐activator 3‐target screening for the development of potent and safe topical therapeutics against skin hyperpigmentary diseases

Author:

Lee Jeong Hyeon1,An Hongchan23,Kwon HyeJi4,Lee Su‐Jeong3,Park Young Hye3,Hwang Ji Sun3,Kim Min Young3,Hwang Hayoung3,Kim Jeong Yoon4,Lee Seung Jin4,Chang Sung Eun1,Song Youngsup4ORCID

Affiliation:

1. Department of Dermatology University of Ulsan College of Medicine, Asan Medical Center Seoul South Korea

2. College of Pharmacy and Institute of Pharmaceutical Sciences CHA University Pocheon South Korea

3. New Drug Development Center (NDDC) Daegu‐Gyeongbuk Medical Innovation Foundation (DGMIF) Daegu South Korea

4. Department of Brain Science Brain Korea 21 project University of Ulsan College of Medicine, Asan Medical Center Seoul South Korea

Funder

National Research Foundation of Korea

Publisher

Wiley

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3